Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: Comparison of plasma levels in central venous and pulmonary venous blood

Thrombosis Research

Volumn 97, Issue 3, 2000, Pages 105-111

  Kalweit, Gerhard A ^a   Feindt, Peter ^a   Micek, Mario ^a   Gams, Emmeran ^a   Hellstern, Peter ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Academic City Hospital   (Germany)

Author keywords

Activated hemostasis; D dimers; Fibrinolysis, Pulmonary malignancies; Markers of thrombin generation

Indexed keywords

ANTITHROMBIN; D DIMER; MARKER; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL;

AGED; ANTIFIBRINOLYTIC AGENTS; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HEMOSTASIS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PNEUMONECTOMY; PROTEIN PRECURSORS; PROTHROMBIN; PULMONARY VEINS; SURVIVAL RATE; THROMBOPHILIA; VENA CAVA, SUPERIOR;

EID: 0033955775     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00161-9     Document Type: Article

References (22)

1. Nand S., Messmore H. Hemostasis in malignancy. Am J Hematol. 35:1990;45-55.
2. Gabazza E.C., Taguchi O., Yamakami T., Machishi M., Ibata H., Suzuki S. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer. Cancer. 72:1993;2134-2140.
3. Green K.B., Silverstein R.L. Hypercoagulability in cancer. Hematol Oncol Clin North Am. 10:1996;499-530.
4. Francis J.L., Biggerstaff J., Amirkhosravi A. Hemostasis and malignancy. Semin Thromb Hemost. 24:1998;93-109.
5. Trousseau A. Phlegmasia alba dolens. In: Anonymous. Clinique medicale de l'Hotel-Dieu de Paris. London: The New Sydenham Society; 1865. p. 94-6.
6. Kalweit G., Huwer H., Volkmer I., Petzold T., Gams E. Pulmonary embolism. A frequent cause of acute fatality after lung resection Eur J Cardiothorac Surg. 10:1996;242-247.
7. Fengler S.A., Berenberg J.L., Lee Y.L. Disseminated coagulopathies and advanced malignancies. Am Surg. 56:1990;335-338.
8. Costantini V., De Monte P., Cazzato A.O., Atabile A.M., Develglia R., Frezzato E., Paolucci M.C. Systemic thrombin generation in cancer patients is correlated with extrinsic pathway activation. Blood Coag Fibrinol. 9:1998;79-84.
9. Sack J.G.H., Levine J., Bell W.R. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms. Clinical, pathophysiologic and therapeutical features Medicine. 56:1977;1-37.
10. Rickles F.R., Edwards R.L. Activation of blood coagulation in cancer. Trousseau's syndrome revisited Blood. 62:1983;14-31.
11. Gabazza E.C., Taguchi O., Yamakami T., Machishi M., Ibata H., Suzuki S. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer. Cancer. 72:1993;2134-2140.
12. Rickles F.R., Levine M., Edwards R.L. Hemostatic alterations in cancer patients. Cancer Metastasis Rev. 11:1992;237-248.
13. Bauer K.A., Goodman T.L., Kass B.L., Rosenberg R.D. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest. 76:1985;826-836.
14. Sherman M.A., Pizzo S.V. The in vivo metabolism of antithrombin III complex. J Biol Chem. 257:1983;8243-8248.
15. Nossel H.L., Yudelman I., Canfield R.E., Butler V.P., Spanondis K., Wilner G.D., Qureshi G.D. Measurement of fibrinopeptide A in human blood. J Clin Invest. 54:1974;43-53.
16. Merlini P.A., Ardissino D. Laboratory measurement of thrombin activity - What every clinician scientist needs to know. J Thromb Thrombolysis. 2:1995;85-92.
17. Falanga A., Barbui T., Rickles F.R., Levine M.N. Guidelines for clotting studies in cancer patients. Thromb Haemost. 70:1993;540-542.
18. Kakkar A.K., De Rovo N., Chinswangwatanakul V., Tebbutt S., Williamson R.C.N. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet. 346:1995;1004-1005.
19. Kambayashi J., Sakon M., Yokota M., Shiba E., Kawasaki T., Mori T. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers. Thromb Res. 60:1990;157-167.
20. Dahl O.E., Pedersen T., Kierulf P., Westvick Å, Lund P., Arnesen H., Seljeflot I., Abdelnoor M., Lyberg T. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res. 70:1993;451-458.
21. Dahl O.E. The role of pulmonary circulation in the regulation of coagulation and fibrinolysis in relation to major surgery. J Cardiothorac Vasc Anesth. 11:1997;322-328.
22. Eriksson E., Risberg B. Tissue plasminogen activator and its inhibitor following major surgery in relation to ventilatory pattern. Acta Chir Scand. 154:1988;57-60.